Dysregulation of PRMT1 activity and expression is significantly associated with the pathogenesis of various immune‐mediated diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), asthma, and chronic graft‐versus‐host disease (cGVHD). This evidence concerns the gene PRMT1 and systemic lupus erythematosus.